Vivus, Why the Slide? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus, Why the Slide?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Singer who wrote (2896)	7/31/1997 12:04:00 AM
From: Frostman	of 3991

Richard, great analysis; that $44 looks on course. The UK announcement tomorrow at 9am wouldn't hurt a bit, would it? A few additional elements that make VVUS interesting for me are: a)the potential of another stock-split before the end of the year. b) the potential for exceptional sales in the UK following the product launch in September or October. c)the very real availability of an additional $15 million in combined milestone payments from Astra and Janssen as full marketing approval is obtained in other countries. d) potential delay of FDA approval of competitive products. e) I liked the way VVUS stepped up to the plate and bought back 3 million dollars in common stock (151,000 shares) in second quarter. They have the funds to pull off another chest-banging move like that again this year. Frostman Welcome aboard Mr. Strang. You will not be bored, THAT is the one true VVUS guarantee!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next